Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

John Corboy

Concepts (369)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Multiple Sclerosis
47
2024
380
8.340
 Why?
Multiple Sclerosis, Relapsing-Remitting
14
2024
69
3.120
 Why?
Neurology
10
2018
85
2.510
 Why?
Immunosuppressive Agents
10
2024
666
1.820
 Why?
Immunologic Factors
11
2020
219
1.710
 Why?
Neuromyelitis Optica
4
2023
114
1.260
 Why?
Natalizumab
11
2021
46
1.010
 Why?
Recurrence
7
2024
950
0.790
 Why?
Diagnostic Errors
2
2017
151
0.780
 Why?
Internship and Residency
5
2011
957
0.760
 Why?
Drug Substitution
2
2019
46
0.700
 Why?
Fingolimod Hydrochloride
5
2020
30
0.690
 Why?
Rituximab
4
2020
149
0.650
 Why?
Brain
14
2021
2372
0.650
 Why?
Data Collection
4
2011
637
0.640
 Why?
Dementia, Vascular
3
2009
17
0.630
 Why?
Drug Monitoring
1
2019
184
0.610
 Why?
Early Medical Intervention
1
2017
51
0.570
 Why?
Medication Adherence
2
2019
537
0.570
 Why?
Early Diagnosis
2
2017
220
0.560
 Why?
Glatiramer Acetate
6
2019
20
0.540
 Why?
Physicians
4
2016
777
0.540
 Why?
Calcinosis
2
2009
244
0.510
 Why?
Antibodies, Monoclonal, Humanized
8
2023
666
0.510
 Why?
Postural Balance
3
2018
182
0.510
 Why?
Humans
79
2024
115859
0.490
 Why?
Magnetic Resonance Imaging
23
2023
3072
0.470
 Why?
Fatigue
3
2018
296
0.430
 Why?
Dimethyl Fumarate
3
2020
10
0.400
 Why?
Immunoglobulin G
4
2023
782
0.390
 Why?
Practice Guidelines as Topic
1
2018
1405
0.360
 Why?
Multiple Sclerosis, Chronic Progressive
3
2020
25
0.360
 Why?
Withholding Treatment
2
2021
69
0.350
 Why?
Middle Aged
37
2021
27078
0.330
 Why?
Psychiatry
2
2009
155
0.330
 Why?
Adult
41
2023
30814
0.310
 Why?
Cysts
1
2009
94
0.310
 Why?
Demyelinating Diseases
4
2019
75
0.310
 Why?
Education, Medical
1
2011
225
0.310
 Why?
Certification
1
2008
90
0.300
 Why?
Autoantibodies
3
2023
1362
0.300
 Why?
Clinical Trials as Topic
3
2016
944
0.290
 Why?
Education
2
2007
99
0.280
 Why?
Central Nervous System Cysts
1
2006
12
0.280
 Why?
Cerebral Arteries
1
2006
55
0.270
 Why?
Myelin-Oligodendrocyte Glycoprotein
2
2023
43
0.270
 Why?
Single-Blind Method
3
2023
256
0.270
 Why?
Cerebrovascular Disorders
1
2006
82
0.270
 Why?
Societies, Medical
4
2019
685
0.260
 Why?
Treatment Outcome
12
2023
9163
0.260
 Why?
Female
46
2023
60070
0.260
 Why?
HIV Long Terminal Repeat
2
1997
7
0.260
 Why?
DNA, Viral
2
1998
351
0.260
 Why?
Databases, Factual
3
2016
1137
0.250
 Why?
Double-Blind Method
4
2023
1664
0.240
 Why?
Male
36
2023
56103
0.240
 Why?
Drug Industry
2
2016
104
0.240
 Why?
Conflict of Interest
2
2016
120
0.230
 Why?
Encephalomyelitis, Autoimmune, Experimental
1
2023
50
0.220
 Why?
B-Lymphocytes
5
2023
771
0.200
 Why?
Quality of Health Care
2
2017
577
0.200
 Why?
Mental Disorders
2
2007
903
0.200
 Why?
Brain Neoplasms
4
2016
979
0.200
 Why?
Lymphoma
2
2005
177
0.200
 Why?
Interferon beta-1a
2
2019
12
0.190
 Why?
Central Nervous System Neoplasms
2
2005
125
0.190
 Why?
Neuroimaging
1
2023
248
0.190
 Why?
Education, Medical, Continuing
2
2015
119
0.190
 Why?
Lymphopenia
1
2020
49
0.180
 Why?
Disease Progression
4
2021
2423
0.180
 Why?
Agammaglobulinemia
1
2020
31
0.180
 Why?
Referral and Consultation
1
2005
647
0.180
 Why?
Interferon-gamma
1
2023
733
0.170
 Why?
Neutropenia
1
2020
127
0.170
 Why?
Serum Sickness
1
2019
7
0.170
 Why?
Indans
1
2019
9
0.170
 Why?
Oxadiazoles
1
2019
32
0.170
 Why?
Diagnosis, Differential
4
2023
1359
0.170
 Why?
Adjuvants, Immunologic
3
2015
206
0.160
 Why?
Educational Measurement
3
2015
265
0.150
 Why?
Salvage Therapy
1
2019
128
0.150
 Why?
Lymphoma, AIDS-Related
1
1998
13
0.150
 Why?
Physician-Patient Relations
2
2016
467
0.150
 Why?
Hematopoietic Stem Cell Transplantation
2
2019
524
0.150
 Why?
Eye Movements
1
2018
53
0.150
 Why?
Drug-Related Side Effects and Adverse Reactions
1
2020
242
0.150
 Why?
Herpesvirus 8, Human
1
1998
63
0.150
 Why?
AIDS Dementia Complex
1
1997
50
0.150
 Why?
Diffuse Cerebral Sclerosis of Schilder
1
2017
4
0.150
 Why?
Central Nervous System
2
2005
239
0.150
 Why?
Patient Selection
2
2015
655
0.150
 Why?
Sarcoma, Kaposi
1
1998
69
0.150
 Why?
Herpesvirus 4, Human
1
2018
123
0.150
 Why?
HIV Seropositivity
1
1998
110
0.140
 Why?
Young Adult
6
2023
10508
0.140
 Why?
Neurologists
1
2016
18
0.140
 Why?
Herpesviridae Infections
1
1998
138
0.140
 Why?
Costs and Cost Analysis
1
2017
200
0.140
 Why?
Cost-Benefit Analysis
2
2016
548
0.130
 Why?
Aged
8
2023
19292
0.130
 Why?
Estriol
1
2015
5
0.130
 Why?
T-Lymphocytes
1
2023
1758
0.130
 Why?
Dizziness
2
2018
70
0.130
 Why?
Verbal Learning
2
2013
63
0.130
 Why?
Corpus Callosum
2
2006
57
0.130
 Why?
Follow-Up Studies
6
2020
4443
0.130
 Why?
Diffusion Magnetic Resonance Imaging
2
2006
85
0.120
 Why?
Trust
1
2016
108
0.120
 Why?
Retrospective Studies
9
2020
12615
0.120
 Why?
Ethics, Medical
1
2015
70
0.120
 Why?
Mesenchymal Stem Cell Transplantation
1
2014
37
0.120
 Why?
Exercise Therapy
1
2018
353
0.120
 Why?
Insurance, Health
1
2016
247
0.110
 Why?
Medication Reconciliation
1
2013
25
0.110
 Why?
CD40 Antigens
1
2014
80
0.110
 Why?
T-Lymphocytes, Helper-Inducer
1
2014
129
0.110
 Why?
Anti-Inflammatory Agents
2
2006
447
0.110
 Why?
JC Virus
1
2013
23
0.110
 Why?
Population Surveillance
1
2016
395
0.110
 Why?
Sensation Disorders
1
2012
30
0.110
 Why?
Glioma
1
2016
296
0.100
 Why?
Memory Disorders
1
2013
155
0.100
 Why?
Immune Reconstitution Inflammatory Syndrome
1
2012
18
0.100
 Why?
Immunoglobulin Heavy Chains
3
2007
72
0.100
 Why?
Leukoencephalopathy, Progressive Multifocal
1
2012
38
0.100
 Why?
Lymphoma, T-Cell, Peripheral
1
2012
15
0.100
 Why?
Optic Nerve
2
2005
65
0.100
 Why?
T-Lymphocyte Subsets
1
2014
383
0.100
 Why?
Quality of Life
3
2021
2390
0.090
 Why?
Gadolinium
4
2018
78
0.090
 Why?
Learning
1
2015
358
0.090
 Why?
Self-Assessment
1
2011
63
0.090
 Why?
Academies and Institutes
1
2011
44
0.090
 Why?
Biomarkers
3
2014
3474
0.090
 Why?
Nervous System Diseases
1
2013
253
0.090
 Why?
Nerve Regeneration
1
2010
53
0.090
 Why?
Fatal Outcome
3
2006
286
0.090
 Why?
Diagnostic Tests, Routine
1
2011
89
0.090
 Why?
Antigens, CD19
3
2007
97
0.090
 Why?
Leukocytosis
1
2010
35
0.090
 Why?
Exercise Test
1
2012
541
0.090
 Why?
Severity of Illness Index
3
2014
2590
0.090
 Why?
Cranial Nerve Neoplasms
1
1989
6
0.090
 Why?
Hemangioma, Cavernous
1
1989
15
0.090
 Why?
Optic Chiasm
1
1989
18
0.090
 Why?
Central Nervous System Infections
1
2010
36
0.080
 Why?
United States
7
2019
12319
0.080
 Why?
Disease Management
1
2013
563
0.080
 Why?
Guidelines as Topic
1
2011
247
0.080
 Why?
Spinal Cord
3
2023
351
0.080
 Why?
Neuroprotective Agents
1
2009
105
0.080
 Why?
Physical Therapy Modalities
1
2011
269
0.080
 Why?
Practice Patterns, Physicians'
1
2016
1182
0.080
 Why?
Workload
1
2009
133
0.080
 Why?
Hospital-Physician Relations
1
2007
2
0.070
 Why?
Antibodies, Monoclonal
2
2011
1264
0.070
 Why?
Neuropsychological Tests
2
2013
918
0.070
 Why?
Immunoglobulin Variable Region
2
2004
72
0.070
 Why?
HIV-1
1
1992
771
0.070
 Why?
Headache Disorders
1
2006
12
0.070
 Why?
Vasculitis, Central Nervous System
1
2006
17
0.070
 Why?
Nerve Fibers, Myelinated
1
2006
41
0.070
 Why?
Huntington Disease
1
2007
38
0.070
 Why?
Medical Records
1
2007
157
0.070
 Why?
Glial Fibrillary Acidic Protein
1
2006
82
0.070
 Why?
Syndrome
2
2023
339
0.070
 Why?
International Classification of Diseases
1
2007
118
0.070
 Why?
Methylprednisolone
1
2006
83
0.070
 Why?
Contrast Media
3
2018
365
0.070
 Why?
Antibody Formation
1
2007
274
0.070
 Why?
Intracranial Hemorrhages
1
2006
76
0.070
 Why?
Aquaporin 4
1
2006
86
0.070
 Why?
Fellowships and Scholarships
1
2009
241
0.070
 Why?
Herpes Zoster
1
2010
333
0.070
 Why?
Canada
2
2019
337
0.070
 Why?
Surveys and Questionnaires
4
2016
4673
0.060
 Why?
DNA Mutational Analysis
1
2006
378
0.060
 Why?
RNA, Messenger
1
1992
2581
0.060
 Why?
Patient Compliance
1
2009
524
0.060
 Why?
Health Care Surveys
1
2007
540
0.060
 Why?
Erythrocytes
1
2010
590
0.060
 Why?
Cognition Disorders
1
2009
475
0.060
 Why?
Teaching
1
2007
226
0.060
 Why?
Affect
1
2007
244
0.060
 Why?
Neurologic Examination
1
2005
116
0.060
 Why?
Analysis of Variance
3
2015
1227
0.060
 Why?
Program Evaluation
1
2009
841
0.060
 Why?
Central Nervous System Diseases
1
2005
62
0.060
 Why?
Neutrophils
1
2010
1171
0.060
 Why?
Simvastatin
1
2004
59
0.060
 Why?
Faculty, Medical
1
2006
234
0.060
 Why?
Ophthalmoplegia
1
2003
8
0.060
 Why?
Proteoglycans
1
2004
108
0.060
 Why?
Diagnostic Techniques, Ophthalmological
1
2003
36
0.060
 Why?
Adolescent
7
2021
17935
0.050
 Why?
B-Lymphocyte Subsets
1
2003
67
0.050
 Why?
Cyclophosphamide
1
2003
218
0.050
 Why?
Anticoagulants
1
2006
549
0.050
 Why?
Radiography
1
2005
826
0.050
 Why?
Cross-Sectional Studies
1
2012
4447
0.050
 Why?
Academic Medical Centers
1
2005
416
0.050
 Why?
Students, Medical
1
2006
280
0.050
 Why?
Dementia
1
2005
185
0.050
 Why?
Membrane Glycoproteins
1
2004
433
0.050
 Why?
Infusions, Intravenous
1
2023
374
0.050
 Why?
Lymphoma, B-Cell
2
2005
85
0.050
 Why?
Patient Outcome Assessment
1
2023
123
0.050
 Why?
Peptides
3
2013
864
0.050
 Why?
Clinical Competence
1
2008
924
0.050
 Why?
Time Factors
4
2018
6182
0.050
 Why?
Pain
1
2007
712
0.050
 Why?
Schools, Medical
1
2002
125
0.050
 Why?
Disability Evaluation
2
2014
271
0.050
 Why?
Molecular Sequence Data
3
2004
2796
0.050
 Why?
Antibodies, Antinuclear
1
2001
60
0.050
 Why?
Consensus
1
2023
531
0.050
 Why?
Atrophy
1
2021
152
0.050
 Why?
Child
5
2016
18537
0.050
 Why?
Mobility Limitation
1
2020
60
0.040
 Why?
Antibodies, Viral
1
2023
527
0.040
 Why?
Interferon-beta
2
2011
80
0.040
 Why?
Lymphocyte Activation
1
2003
1056
0.040
 Why?
Lipids
1
2023
589
0.040
 Why?
Maintenance Chemotherapy
1
2019
22
0.040
 Why?
Induction Chemotherapy
1
2019
56
0.040
 Why?
Cerebral Infarction
1
1998
39
0.040
 Why?
Cell Separation
2
2014
293
0.040
 Why?
Transplantation, Autologous
1
2019
175
0.040
 Why?
HIV Seronegativity
1
1998
24
0.040
 Why?
Genes, myc
1
1998
47
0.040
 Why?
Astrocytoma
1
1998
108
0.040
 Why?
Risk Assessment
1
2006
2992
0.040
 Why?
In Situ Hybridization
1
2018
298
0.040
 Why?
Gene Library
1
1997
117
0.040
 Why?
Gene Rearrangement
1
1998
136
0.040
 Why?
Breast Neoplasms
1
2008
1872
0.040
 Why?
Real-Time Polymerase Chain Reaction
1
2018
319
0.040
 Why?
Syndecan-1
2
2007
28
0.030
 Why?
Flow Cytometry
2
2014
1060
0.030
 Why?
Mutation
1
2006
3371
0.030
 Why?
Viral Load
1
2018
406
0.030
 Why?
Drug Administration Schedule
1
2018
724
0.030
 Why?
Colorado
1
2005
4122
0.030
 Why?
Child, Preschool
3
2016
9164
0.030
 Why?
Polymerase Chain Reaction
1
1998
1001
0.030
 Why?
Survival Analysis
1
2018
1218
0.030
 Why?
Health Knowledge, Attitudes, Practice
2
2016
1193
0.030
 Why?
Sequence Analysis, DNA
1
1997
737
0.030
 Why?
Patient Care Team
1
2019
522
0.030
 Why?
Incidence
1
2020
2336
0.030
 Why?
Base Sequence
1
1997
2121
0.030
 Why?
Congresses as Topic
1
2015
204
0.030
 Why?
Propylene Glycols
1
2013
26
0.030
 Why?
Ocular Physiological Phenomena
1
1992
11
0.030
 Why?
Sphingosine
1
2013
32
0.030
 Why?
HLA-DR Antigens
1
2014
220
0.030
 Why?
beta-Galactosidase
1
1992
63
0.030
 Why?
Drug Therapy, Combination
1
2015
962
0.030
 Why?
Quality-Adjusted Life Years
1
2013
103
0.030
 Why?
Markov Chains
1
2013
115
0.030
 Why?
Mice
2
2023
15085
0.030
 Why?
Mice, Inbred DBA
1
1992
173
0.030
 Why?
Animals
3
2023
32158
0.030
 Why?
Haplotypes
1
2014
475
0.030
 Why?
Mental Recall
1
2013
173
0.030
 Why?
Comparative Effectiveness Research
1
2013
130
0.030
 Why?
Organ Specificity
1
1992
274
0.030
 Why?
Reference Values
1
2013
745
0.030
 Why?
Depression
2
2011
1145
0.030
 Why?
CD3 Complex
1
2012
92
0.020
 Why?
Intestine, Small
1
1992
125
0.020
 Why?
Ki-67 Antigen
1
2012
104
0.020
 Why?
Thymus Gland
1
1992
298
0.020
 Why?
Mitoxantrone
1
2011
12
0.020
 Why?
Patient Participation
1
2015
362
0.020
 Why?
Hematologic Tests
1
2011
22
0.020
 Why?
Muscle Stretching Exercises
1
2011
17
0.020
 Why?
Clinical Laboratory Techniques
1
2011
87
0.020
 Why?
Randomized Controlled Trials as Topic
2
2006
1217
0.020
 Why?
Aged, 80 and over
2
2016
6434
0.020
 Why?
Physical Endurance
1
2011
223
0.020
 Why?
Recombinant Fusion Proteins
1
1992
617
0.020
 Why?
Amino Acid Sequence
2
2004
2003
0.020
 Why?
Prevalence
1
2016
2270
0.020
 Why?
Acyclovir
1
2010
100
0.020
 Why?
Spinal Cord Neoplasms
1
1989
40
0.020
 Why?
Respiratory Function Tests
1
2011
539
0.020
 Why?
Cell Count
1
2010
304
0.020
 Why?
History, 19th Century
1
2009
56
0.020
 Why?
Pilot Projects
2
2004
1379
0.020
 Why?
Neoplasms, Multiple Primary
1
1989
52
0.020
 Why?
Injections
1
2009
162
0.020
 Why?
History, 21st Century
1
2009
164
0.020
 Why?
Autoimmunity
1
2014
823
0.020
 Why?
Electrocardiography
1
2011
560
0.020
 Why?
History, 20th Century
1
2009
275
0.020
 Why?
Mice, Transgenic
1
1992
1971
0.020
 Why?
Age of Onset
1
2009
455
0.020
 Why?
Gene Expression
1
1992
1442
0.020
 Why?
Memory
1
2009
211
0.020
 Why?
Walking
1
2011
426
0.020
 Why?
Health
1
2007
74
0.020
 Why?
CD8-Positive T-Lymphocytes
1
2012
688
0.020
 Why?
Prognosis
2
2006
3344
0.020
 Why?
Association Learning
1
2007
60
0.020
 Why?
Cerebral Ventricles
1
2006
47
0.020
 Why?
Motor Skills
1
2007
80
0.020
 Why?
Hospitalization
1
2015
1764
0.020
 Why?
Phenotype
1
2014
2859
0.020
 Why?
Herpesvirus 3, Human
1
2010
381
0.020
 Why?
Immunologic Memory
1
2007
312
0.020
 Why?
Hypothalamus
1
2006
150
0.020
 Why?
Social Support
1
2009
538
0.020
 Why?
Genetics
1
2005
27
0.020
 Why?
Neurosciences
1
2005
20
0.020
 Why?
Models, Theoretical
1
2009
520
0.020
 Why?
Image Interpretation, Computer-Assisted
1
2006
219
0.020
 Why?
Clinical Protocols
1
2006
234
0.020
 Why?
Syndecans
1
2004
5
0.020
 Why?
Internet
1
2009
601
0.020
 Why?
Anisotropy
1
2004
62
0.010
 Why?
Antiviral Agents
1
2010
651
0.010
 Why?
Risk Factors
2
2008
8715
0.010
 Why?
Plasma Cells
1
2004
57
0.010
 Why?
Immune System
1
2005
173
0.010
 Why?
Gene Rearrangement, B-Lymphocyte, Light Chain
1
2003
4
0.010
 Why?
Gene Rearrangement, B-Lymphocyte, Heavy Chain
1
2003
12
0.010
 Why?
Videotape Recording
1
2003
30
0.010
 Why?
Infrared Rays
1
2003
21
0.010
 Why?
Lymphoma, Large B-Cell, Diffuse
1
2005
93
0.010
 Why?
Meningitis, Viral
1
2003
21
0.010
 Why?
Feasibility Studies
1
2006
750
0.010
 Why?
Saccades
1
2003
35
0.010
 Why?
Antilymphocyte Serum
1
2003
66
0.010
 Why?
Oligoclonal Bands
1
2003
21
0.010
 Why?
Astrocytes
1
2005
165
0.010
 Why?
Mice, Inbred C57BL
1
1992
4779
0.010
 Why?
Microglia
1
2005
205
0.010
 Why?
Antigens, CD34
1
2003
97
0.010
 Why?
Clone Cells
1
2003
247
0.010
 Why?
Whole-Body Irradiation
1
2003
72
0.010
 Why?
Receptors, Antigen, B-Cell
1
2003
102
0.010
 Why?
Immunoglobulins
1
2003
148
0.010
 Why?
Observer Variation
1
2003
298
0.010
 Why?
Longitudinal Studies
1
2009
2416
0.010
 Why?
Tomography, X-Ray Computed
1
2012
2404
0.010
 Why?
Sex Characteristics
1
2007
643
0.010
 Why?
Age Factors
1
2009
2911
0.010
 Why?
Administration, Oral
1
2004
733
0.010
 Why?
Infant
1
2015
7992
0.010
 Why?
Urinary Tract Infections
1
2003
136
0.010
 Why?
Biopsy
1
2005
1056
0.010
 Why?
Cohort Studies
1
2011
4960
0.010
 Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2003
935
0.010
 Why?
Immunoglobulin kappa-Chains
1
2001
18
0.010
 Why?
Predictive Value of Tests
1
2006
1813
0.010
 Why?
Cytomegalovirus Infections
1
2003
181
0.010
 Why?
Acute Disease
1
2003
917
0.010
 Why?
Immunoglobulin Fab Fragments
1
2001
69
0.010
 Why?
Combined Modality Therapy
1
2003
1127
0.010
 Why?
Research
1
2003
398
0.010
 Why?
Lung
1
1992
3683
0.010
 Why?
Survival Rate
1
2003
1649
0.010
 Why?
Sensitivity and Specificity
1
2003
1725
0.010
 Why?
Arachnoid
1
1998
9
0.010
 Why?
Models, Biological
1
2005
1647
0.010
 Why?
Case-Control Studies
1
2004
3054
0.010
 Why?
Aging
1
2007
1635
0.010
 Why?
Reproducibility of Results
1
2003
2807
0.010
 Why?
Corboy's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (369) concept(s)
_
Co-Authors Expand Description
See all (34) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2024 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)